Title: Introduction and Update on the Fundamentals of Genomics: part 1
1Introduction and Update on the Fundamentals of
Genomicspart 1
- Washington State Board of Health
- Genetics Task Force Meeting
- January 3, 2002
- David L. Eaton, Ph.D.Director,
- Center for Ecogenetics Environmental Health
Associate Dean for Research - School of Public Health Community Medicine
- University of Washington
2Overview of todays talk
- Fundamentals of molecular biology
- Structure of genes and chromosomes
- The Human Genome Project
- How genetic alterations cause, or contribute to,
disease - How genomics will influence the practice of
medicine in the future - Ethical, Legal and Social Implications
- Dr. Burke will expand on this
3From the DOE Human Genome Program
http//www.ornl.gov/hgmis
4From the DOE Human Genome Program
http//www.ornl.gov/hgmis
5Gene Expression
DNA ? RNA ? Protein
RNA Transcription
Protein Translation
6Gene Structure and Expression
Exons
Promoter
I
III
DNA
II
Introns
Transcription
I
III
II
PrimaryRNA
(Temporary)
Splicing
II
III
I
mRNA
(Mature)
Protein
Translation
Exons
7Two discoveries that changed the world of biology
and medicine
- Soil microorganisms that express restriction
enzymes - Selectively cut DNA at specific nucleotide
sites - Recognition sites of 3-8 base pairs
- RFLP - primary basis for forensic DNA fingerprint
- Thermophilic bacteria
- Express heat stable DNA polymerases
- Allows fragments of DNA to be copied, melted
and re-copied - Polymerase Chain Reaction (PCR)
8The Human Genome ProjectObjectives
- 1. Sequence the entire human genome
- 2. Develop technology for sequencing
- 3. Identify variation in sequence
- 4. Interpret function (functional genomics)
- 5. Sequence model organisms (yeast, round worm,
fruit fly, mouse) - 6. Examine Ethical, Legal and Social Issues
(ELSI) - 7. Develop bioinformatics and computation
- 8. Train scientists
9Human Genome 3,000,000,000 base pairs
An analogy - the genome encyclopedia
average 5 letters per word gt 600,000,000
words average 12 words per line gt
50,000,000 lines average 70 lines per page
gt 700,000 pages
10Genetic Determinants of Disease
- Chromosomal abnormalities
- Loss or gain of chromosomes
- Loss or gain of chromosomal regions
- Chromosomal translocation
- Single gene mutations
- Coding regions loss, gain, or alteration of
protein function - Regulatory regions increased, decreased or
inappropriate expression - Polygenic or multifactorial problems
- Multiple gene mutations
- Gene/Gene, Gene-Environment interactions
11Genetic Mutations are Alterations in DNA Sequence
- Natural (spontaneous) mutations are changes
induced by cellular processes such as mis-copying
DNA, or oxidative damage to DNA - Induced mutations are caused by environment,
i.e., diet, chemicals, radiation, viruses,
lifestyle - Most Mutations are repaired efficiently, but
errors occur - Mutations can be harmful or helpful
- Most mutations have no known function
12Human Variability in DNA(polymorphism)
- SNPs (single nucleotide polymorphisms)
- indels (insertions and deletions)
- Chromosomal rearrangements
- Repetitive sequence (alu, di- and tri-nucleotide
repeats - microsatellites) - Gene duplication
- Pseudogenes (non-transcribed exonic sequence with
high homology to an expressed gene)
13How common are SNPs?
- On average, 1 nucleotide difference per 1,000
nucleotides when comparing the same gene in two
different individuals - Across the human population, average SNP
differences 1 difference/200-400 NT - Non-uniform - 10x higher variability in intronic
vs. exonic sequence - In total, several million NT differences between
any two individuals
Majority of human genome variance is
represented within rather than between populations
14Significance of Polymorphic Variants
- Many examples of highly penetrant allelic
variants that directly cause disease - Huntingtons, cystic fibrosis, Muscular
Dystrophy, etc. - However, most other diseases are clearly
multigenic - a given gene will have limited
penetrance for the disease trait - The environment also plays a big role
15Common Cystic Fibrosis Mutation
Deletion of 3 nucleotides
...Ile Ile Phe Gly...
Normal
...AUC AUC UUU GGU...
...AUC AU- --U GGU...
CF
...Ile Il e Gly...
16Examples of Gene-Environment Interactions
- PKU and consumption of phenylalanine
- Malaria and Sickle Cell gene
- HIV infection and CCR5 receptor variant
- Adverse drug response and CYP2D6 poor metabolism
- Alcohol intolerance and aldehyde dehydrogenase
- Smoking, Bladder cancer risk glutathione
S-transferase M1 null genotypes and NAT2 slow
genotypes
17Genetic Modulation of Exposure Risk
No Exposure
Exposure
18Implications of Genomicsto the Practice of
Medicine
- Discern the molecular basis of diseases
- Key component to prevention
- Better and earlier diagnosis
- Molecular biomarkers of early stages
- More effective and selective treatment
- Will require difficult cost-benefit decisions
- Policy makers
- Pharmaceutical companies
- Insurance companies / HMOs, etc.
- Physicians, providers
19Implications of Genomicsto the Practice of
Medicine
- Pharmacogenomics
- Taylor the drug to the patient
- gene chips will identify
- variant kinetics (absorption, distribution,
metabolism, excretion) - variant receptors - selective efficacy
- Predict / avoid adverse drug responses
- Examples
- Thipurine methyl transferase deficiency
- N-acetyl transferase slow metabolizers
20Implications of Genomicsto the Practice of
Medicine
- Ecogenetics (gene-environment interactions)
- Susceptible sub-populations
- GSTM1 polymorphism and lung cancer risk
- Genetic response to dietary factors
- Occupational risks
- HLA variants and susceptibility to Berrylium
disease - CYP2E NQO1 variants and benzene toxicity
- Identify / prevent adverse drug - environment
interactions
21Benefits of HGP Research Medical Benefits
- improved diagnosis of disease
- earlier detection of predispositions to disease
- rational drug design
- gene therapy and control systems for drugs
- pharmacogenomics personal drugs
- organ replacement
22Ethical, Legal, and Social Implications of HGP
Research
- fairness in the use of genetic information
- privacy and confidentiality
- psychological impact and stigmatization
- genetic testing
- education, standards, and quality control
23(No Transcript)